Study Recommends Alternative Antibiotics for Golden Staph Infections
The global SNAP Trial, published in the New England Journal of Medicine and The Lancet, suggests cefazolin and benzylpenicillin are safer and equally effective treatments for golden staph bloodstream infections compared to flucloxacillin. Patients receiving benzylpenicillin showed reduced kidney damage and lower mortality rates. This research could lead to updated treatment guidelines for a common and serious infection.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.